Immunoregulatory mechanisms in the aging microenvironment: Targeting the senescence-associated secretory phenotype for cancer immunotherapy. [PDF]
Acta Pharm Sin BWang H +6 more
europepmc +1 more source
Anti-senescence therapies: a new concept to address cardiovascular disease. [PDF]
Cardiovasc ResStojanović SD, Thum T, Bauersachs J.
europepmc +1 more source
Exploring the nexus between inflammation and mobility through the lens of healthy aging: current scenario and future perspectives. [PDF]
Aging Clin Exp ResPatusco R, Gyasi K, Kaufmann A.
europepmc +1 more source
Mitochondrial dysfunction and alveolar type II epithelial cell senescence: The destroyer and rescuer of idiopathic pulmonary fibrosis. [PDF]
Front Cell Dev BiolLiu S, Xi Q, Li X, Liu H.
europepmc +1 more source
New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target. [PDF]
BioessaysLégaré C +3 more
europepmc +1 more source
Senescent macrophages in cancer: roles in tumor progression and treatment opportunities. [PDF]
Cancer Biol MedWang T, Liu C, Hu X, Yang N, Qiu C.
europepmc +1 more source
Personalist Bioethics as a Guide to Assessing Emerging Anti-aging Therapies. [PDF]
Linacre QRodríguez-Díaz A +2 more
europepmc +1 more source
Senotherapeutics for metabolic disease and diabetic complications. [PDF]
J Intern MedPalmer AK +7 more
europepmc +1 more source
Cellular senescence and SASP in tumor progression and therapeutic opportunities. [PDF]
Mol CancerDong Z +5 more
europepmc +1 more source